MBIA Inc. (NYSE:MBI) shares advanced 1.78% in last trading session and ended the day at $8.02. MBI has a return on assets of 1.10%. MBIA Inc. (NYSE:MBI) quarterly performance is 29.77%.
MBIA Inc. (NYSE:MBI) had its “buy” rating reiterated by analysts at MKM Partners. They now have a USD 12 price target on the stock.
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) ended the last trading day at $10.43. Company weekly volatility is calculated as 4.22% and price to cash ratio as 11.94. Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) showed a weekly performance of 3.37%.
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) will hold a conference call with investors and analysts on Thursday, May 12th at 8:00 a.m. US Eastern Daylight Time and 8:00 p.m. Taiwan Time to discuss the Company’s first quarter financial results.
KeyCorp. (NYSE:KEY) shares moved up 1.29% in last trading session and ended the day at $12.57. KEY has a return on assets of 0.90%. KeyCorp. (NYSE:KEY) quarterly performance is 15.71%.
On 22 April, KeyCorp (NYSE:KEY) plans to add three First Niagara Financial Group officials to its board this year after the two banks merge.
Henry Schein, Inc. (NASDAQ:HSIC) shares advanced 0.06% in last trading session and ended the day at $172.26. HSIC Gross Margin is 28.30% and its has a return on assets of 7.70%. Henry Schein, Inc. (NASDAQ:HSIC) quarterly performance is 15.72%.
Henry Schein, Inc. (NASDAQ:HSIC) announced its continued support of TeamSmile as the non-profit organization launches its 10th year of partnering with sports teams and volunteers to provide free oral health care to children in need. Since its inception in 2006, TeamSmile has provided more than $8 million in dental and preventive services to more than 18,000 children.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) caters to the Healthcare space. It has a net profit margin of -89.10% and weekly performance is 11.40%. On the last day of trading company shares ended up at $3.42. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) distance from 50-day simple moving average (SMA50) is 9.82%.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced that its first quarter 2016 financial results will be released on Thursday, May 5, 2016.
Leave a Reply